ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,785Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 290

$984K Total Retail Price of All Prescriptions

Rank: 2 out of 290

561 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 561 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 16,189 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
SIMVASTATIN 872 789 1 5
METOPROLOL SUCCINATE 855 770 2 8
ATORVASTATIN CALCIUM 705 643 3 10
WARFARIN SODIUM 688 625 4 7
FUROSEMIDE 667 599 5 4
OMEPRAZOLE 545 480 6 29
POTASSIUM CHLORIDE 510 493 7 14
LISINOPRIL 502 418 8 1
CARVEDILOL 499 424 9 2
AMLODIPINE BESYLATE 492 414 10 6
ISOSORBIDE MONONITRATE ER 466 452 11 9
DIGOXIN 465 429 12 13
METOPROLOL TARTRATE 369 328 13 3
DIOVAN 361 326 14 26
CRESTOR 305 295 15 16
CLOPIDOGREL 297 256 16 11
SPIRONOLACTONE 273 232 17 18
LEVOTHYROXINE SODIUM 270 239 18 31
BYSTOLIC 255 239 19 30
ALLOPURINOL 251 249 20 66
PANTOPRAZOLE SODIUM 236 213 21 45
PLAVIX 200 180 22 12
ZETIA 193 175 23 33
KLOR-CON M20 190 164 24 35
LIPITOR 169 138 25 44
LOSARTAN POTASSIUM 166 166 26 15
RAMIPRIL 163 151 27 28
FENOFIBRATE 156 148 28 61
TRICOR 150 146 29 65
GLIPIZIDE 145 142 30 94
METFORMIN HCL 144 114 31 48
VERAPAMIL ER 143 124 32 76
DILTIAZEM ER 142 135 33 43
COUMADIN 138 138 34 47
TAMSULOSIN HCL 127 127 35 86
LOSARTAN-HYDROCHLOROTHIAZIDE 125 119 36 53
DIOVAN HCT 125 125 36 92
ATENOLOL 125 123 36 20
HYDROCHLOROTHIAZIDE 116 100 39 19
SOTALOL 115 112 40 21
TRILIPIX 110 110 41 104
TRIAMTERENE-HCTZ 109 99 42 49
LOVASTATIN 97 82 43 27
JANUVIA 96 87 44 123
CITALOPRAM HBR 94 79 45 78
ZOLPIDEM TARTRATE 94 93 45 56
DILTIAZEM 24HR CD 93 81 47 23
METFORMIN HCL ER 91 91 48 151
MULTAQ 87 69 49 36
TRAMADOL HCL 85 74 50 64
ISOSORBIDE DINITRATE 77 77 51 75
MELOXICAM 76 63 52 138
RANEXA 75 75 53 38
GABAPENTIN 74 66 54 70
ACTOS 71 71 55 137
EXFORGE 70 68 56 127
NIASPAN 69 60 57 34
NEXIUM 68 58 58 68
ADVAIR DISKUS 68 64 58 99
CALCITRIOL 68 68 58 169
ALENDRONATE SODIUM 63 63 61 111
HYDROCODONE-ACETAMINOPHEN 62 56 S3 62 42
GLIMEPIRIDE 58 46 63 88
AMIODARONE HCL 58 46 63 22
DONEPEZIL HCL 56 56 65 83
DILTIAZEM HCL 56 49 65 82
PRAVASTATIN SODIUM 56 47 65 17
DOXAZOSIN MESYLATE 54 50 68 67
FINASTERIDE 53 53 69 108
NITROSTAT 53 44 69 24
LOVAZA 52 51 71 72
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 51 71 41
ESCITALOPRAM OXALATE 52 52 71 126
CELEBREX 51 51 74 125
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 2, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.